Holen Sie sich die Stockscreener-App
13.70
2.32%
0.31
Handel nachbörslich:
13.89
0.19
+1.39%
Schlusskurs vom Vortag:
$13.39
Offen:
$13.34
24-Stunden-Volumen:
3.32M
Relative Volume:
1.22
Marktkapitalisierung:
$1.18B
Einnahmen:
$139.71M
Nettoeinkommen (Verlust:
$-209.36M
KGV:
-4.6284
EPS:
-2.96
Netto-Cashflow:
$-160.60M
1W Leistung:
+1.26%
1M Leistung:
-10.95%
6M Leistung:
-3.18%
1J Leistung:
-27.36%
1-Tages-Spanne:
$13.30
$14.06
1-Wochen-Bereich:
$12.99
$14.06
52-Wochen-Spanne:
$8.58
$22.50
Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile
Firmenname
Syndax Pharmaceuticals Inc
Sektor
Branche
Telefon
781-419-1400
Adresse
730 THIRD AVENUE, NEW YORK, MA
Vergleichen Sie SNDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNDX
Syndax Pharmaceuticals Inc
|
13.70 | 1.15B | 139.71M | -209.36M | -160.60M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-09-10 | Fortgesetzt | Stifel | Buy |
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-06-28 | Eingeleitet | Jefferies | Buy |
| 2024-01-31 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2023-12-22 | Eingeleitet | Mizuho | Buy |
| 2023-10-25 | Eingeleitet | BofA Securities | Buy |
| 2023-10-11 | Eingeleitet | Goldman | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-07-11 | Eingeleitet | Guggenheim | Buy |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2023-01-31 | Eingeleitet | Stifel | Buy |
| 2023-01-03 | Eingeleitet | JP Morgan | Overweight |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-02-15 | Eingeleitet | Goldman | Buy |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-05-25 | Eingeleitet | Citigroup | Buy |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-05-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-05-18 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-05-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-04 | Eingeleitet | Barclays | Overweight |
| 2020-01-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-01-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-03-16 | Eingeleitet | FBR & Co. | Outperform |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2016-10-07 | Eingeleitet | Guggenheim | Buy |
| 2016-03-28 | Eingeleitet | Citigroup | Buy |
| 2016-03-28 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-03-28 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Syndax Pharmaceuticals Inc Aktie (SNDX) Neueste Nachrichten
Syndax Pharmaceuticals (SNDX) Q3 Earnings Preview: Key Expectati - GuruFocus
Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha
Is Syndax Pharmaceuticals Inc. stock reversal real or fake2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
How risky is Syndax Pharmaceuticals Inc. stock nowJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com
Applying Wyckoff theory to Syndax Pharmaceuticals Inc. stockTrade Volume Summary & Verified Technical Trade Signals - newser.com
Using Ichimoku Cloud for Syndax Pharmaceuticals Inc. technicalsJuly 2025 Outlook & Scalable Portfolio Growth Methods - newser.com
Is Syndax Pharmaceuticals Inc. stock poised for growthJuly 2025 Reactions & Short-Term High Return Strategies - newser.com
Y Intercept Hong Kong Ltd Makes New Investment in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
B. Riley Issues Optimistic Estimate for SNDX Earnings - MarketBeat
Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Previe - GuruFocus
Is it too late to sell Syndax Pharmaceuticals Inc.Weekly Investment Report & Expert Curated Trade Ideas - newser.com
Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price Pressure - Markets Mojo
Detecting support and resistance levels for Syndax Pharmaceuticals Inc.Earnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Syndax Pharmaceuticals’ Promising AML Study Update: Key Insights for Investors - TipRanks
Is Syndax Pharmaceuticals Inc. (1T3) stock considered safe havenJuly 2025 Sentiment & Fast Moving Stock Watchlists - newser.com
Why Syndax Pharmaceuticals Inc. stock is rated strong buyJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
Is Syndax Pharmaceuticals Inc. showing signs of accumulationJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Published on: 2025-10-30 09:56:20 - newser.com
Syndax Pharmaceuticals Launches Promising Phase 3 AML Study with Revumenib - MSN
Syndax Announces Participation in November Investor Conferences - The Manila Times
Is Syndax Pharmaceuticals Inc. (1T3) stock a buy during volatile marketsEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Syndax (Nasdaq: SNDX) to join fireside chats at UBS, Guggenheim, Stifel, Jefferies - Stock Titan
Syndax Pharmaceuticals (SNDX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Is Syndax Pharmaceuticals Inc. stock a safe investment in uncertain marketsDividend Hike & AI Driven Stock Price Forecasts - newser.com
Published on: 2025-10-29 05:54:09 - newser.com
Will Syndax Pharmaceuticals Inc. stock maintain momentum in 20252025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com
How Syndax Pharmaceuticals Inc. stock performs in stagflationTrade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com
Leading vs lagging indicators on Syndax Pharmaceuticals Inc. performanceGold Moves & Free Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-27 23:41:18 - newser.com
Is Syndax Pharmaceuticals Inc. stock positioned for long term growthJuly 2025 Chart Watch & Fast Gaining Stock Reports - Fundação Cultural do Pará
Will Syndax Pharmaceuticals Inc. stock benefit from sector rotation2025 Top Gainers & Precise Buy Zone Identification - Fundação Cultural do Pará
Finanzdaten der Syndax Pharmaceuticals Inc-Aktie (SNDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):